Horse /

Breed profile · FDA CVM July 2026 extract

Welsh Mountain Pony adverse-event record

Adverse-event filings for Welsh Mountain Pony (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

#320 of 510
by report volume (all breeds)
31
FDA CVM reports on file
9.7%
death-coded share of reports
4
INEFFECTIVE, GASTRIC ULCER(S) - top reaction

How the 31 reports break down

By recorded gender -- every report on file for Welsh Mountain Pony, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 5 3.75 2.5 1.25 0 2018 2019 2020 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Welsh Mountain Pony drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Welsh Mountain Pony ranks #318 of 510 by total reports (31). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#318
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Welsh Mountain Pony has 31 reports now versus 30 in that prior snapshot: 1 more (3.3%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Welsh Mountain Pony changes

Total Reports

31

Below-median volume

Deaths Reported

3

of 31 reports

Death-coded share of reports

9.7%

9.7% death-coded

Avg Age at Report

16.2 yr

337.8 kg avg weight

Death-Coded Outcome Share

Welsh Mountain Pony death-coded reports 9.7%
Cross-breed median

9.7% of 31 welsh mountain pony reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 337.8 kg (744.8 lbs)

Top Reported Reactions

INEFFECTIVE, GASTRIC ULCER(S) 4
Lack of efficacy - NOS 4
Diarrhoea 3
Loose stool 3
Death by euthanasia 3

Most Referenced Drugs

Pergolide Mesylate 10
Omeprazole 10
Polysulfated Glycosaminoglycan 3
Ivermectin + Praziquantel 2
Misoprostal 2

Outcome Breakdown

Recovered/Normal
13 (41.9%)
Outcome Unknown
11 (35.5%)
Ongoing
4 (12.9%)
Euthanized
3 (9.7%)

Gender Distribution

Male 14 (45.2%)
Female 14 (45.2%)
Unknown 3 (9.7%)

Reports by Year

Year Reports Trend
2013 1
2014 2
2015 3
2017 2
2018 3
2019 4
2020 1
2022 1
2023 3
2024 5
2025 5
2026 1

Welsh Mountain Pony: high death-coded share in the FDA CVM extract

Signature read: Welsh Mountain Pony's 9.7% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Welsh Mountain Pony sits at #320 of 510 by report volume among all breeds and #33 of 55 among horse breeds, with 31 reports and 3 (9.7%) death-coded. Mean age at report: 16.2 years, average weight 337.8 kg (744.8 lbs).

Top reported signs: INEFFECTIVE, GASTRIC ULCER(S) (4), Lack of efficacy - NOS (4), Diarrhoea (3). Most-referenced drug: Pergolide Mesylate (10 reports), followed by Omeprazole (10) and Polysulfated Glycosaminoglycan (3).

Outcome coding on 31 status-recorded reports is dominated by Recovered/Normal (41.9%). Annual submissions ranged 1-2,026 across 12 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Welsh Mountain Pony, both outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar average weight

Nearest other-species breeds by reported average weight (337.8 kg here).

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Welsh Mountain Pony?
There are 31 adverse event reports involving Welsh Mountain Pony in the FDA database, of which 3 were death-coded (9.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Welsh Mountain Pony ranks #320 of 510 by report volume among all breeds PlainBreed indexes (#33 of 55 among horse breeds).
Where does Welsh Mountain Pony sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Welsh Mountain Pony is #320 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #33 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Welsh Mountain Pony?
The most commonly reported adverse reactions for Welsh Mountain Pony are INEFFECTIVE, GASTRIC ULCER(S) (4 reports), Lack of efficacy - NOS (4 reports), Diarrhoea (3 reports), Loose stool (3 reports), Death by euthanasia (3 reports).
What drugs are most frequently associated with Welsh Mountain Pony adverse events?
The drugs most frequently referenced in Welsh Mountain Pony adverse event reports are Pergolide Mesylate (10 reports), Omeprazole (10 reports), Polysulfated Glycosaminoglycan (3 reports), Ivermectin + Praziquantel (2 reports), Misoprostal (2 reports).
What is the average age of Welsh Mountain Pony in adverse event reports?
The average age of Welsh Mountain Pony at the time of adverse event reports is 16.2 years, with an average weight of 337.8 kg (744.8 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Welsh Mountain Pony (Horse), extract as of July 2026 extract. 31 reports · 3 death-coded (9.7% of reports, not a mortality rate) · #320 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →